Mary J. Ortner

Amministratore Delegato presso Biophagy, Inc.

Consumer Services

Health Technology

Profilo

Mary J.
Ortner is currently the President & Chief Executive Officer at Biophagy, Inc. Previously, she worked as the Chief Business Officer at SolaranRx, Inc. Dr. Ortner holds a graduate degree from California State University-Los Angeles, an MBA from the University of Connecticut, and a doctorate from the University of Hawai'i at Hilo.

Posizioni attive di Mary J. Ortner

Società	Posizione	Inizio
Biophagy, Inc. Biophagy, Inc. Pharmaceuticals: MajorHealth Technology Biophagy, Inc. is an American biopharmaceutical company that manages standard drug development programs in several therapeutic areas. The company is also developing an OTC/DTC kit that focuses exclusively on autophagy stimulation and individual diagnostic measurement over an extended period. Biophagy's proprietary drug discovery program, CellWatch™, is being used to screen patented compounds in a variety of important disease indications to evaluate structure-activity relationships and develop leads. The company is headquartered at The BioScience Center and was founded by Stuart Rose. The CEO is Mary J. Ortner.	Amministratore Delegato	-

Tutte le posizioni attive di Mary J. Ortner

Precedenti posizioni note di Mary J. Ortner

Società	Posizione	Fine
SolaranRx, Inc. SolaranRx, Inc. BiotechnologyHealth Technology SolaranRx, Inc. develops therapies and companion imaging agents for the treatment of metastatic melanoma. It offers radiolabeled peptide that specifically binds to melanocortin-1 receptors on the surface of melanoma cells to identify patients suitable for treatment and to deliver targeted radiation potentially destroying receptor expressing tumors. The company was founded by Les Stewart and Stuart Rose in 2014 and is headquartered in Albuquerque, NM.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Mary J. Ortner

Formazione di Mary J. Ortner

University of Hawai'i at Hilo	Doctorate Degree
California State University-Los Angeles	Graduate Degree
University of Connecticut	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Mary J. Ortner

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
SolaranRx, Inc. SolaranRx, Inc. BiotechnologyHealth Technology SolaranRx, Inc. develops therapies and companion imaging agents for the treatment of metastatic melanoma. It offers radiolabeled peptide that specifically binds to melanocortin-1 receptors on the surface of melanoma cells to identify patients suitable for treatment and to deliver targeted radiation potentially destroying receptor expressing tumors. The company was founded by Les Stewart and Stuart Rose in 2014 and is headquartered in Albuquerque, NM.	Health Technology
Biophagy, Inc. Biophagy, Inc. Pharmaceuticals: MajorHealth Technology Biophagy, Inc. is an American biopharmaceutical company that manages standard drug development programs in several therapeutic areas. The company is also developing an OTC/DTC kit that focuses exclusively on autophagy stimulation and individual diagnostic measurement over an extended period. Biophagy's proprietary drug discovery program, CellWatch™, is being used to screen patented compounds in a variety of important disease indications to evaluate structure-activity relationships and develop leads. The company is headquartered at The BioScience Center and was founded by Stuart Rose. The CEO is Mary J. Ortner.	Health Technology